Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shahin Lockman

Showing results (141-150 of 268) with videos related to

Pageof 27
Sort By:
The Journal of Infectious Diseases|October 16, 2012
Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in BotswanaJennifer Y Chen, Heather J Ribaudo, Sajini Souda, et al.
The New England Journal of Medicine|July 23, 2019
Neural-Tube Defects and Antiretroviral Treatment Regimens in BotswanaRebecca Zash, Lewis Holmes, Modiegi Diseko, et al.
The Lancet. HIV|July 17, 2019
Long-acting or extended-release antiretroviral products for HIV treatment and prevention in infants, children, adolescents, and pregnant and breastfeeding women: knowledge gaps and research prioritiesSharon Nachman, Claire L Townsend, Elaine J Abrams, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 2, 2013
No clinically significant drug-resistance mutations in HIV-1 subtype C-infected women after discontinuation of NRTI-based or PI-based HAART for PMTCT in BotswanaSajini Souda, Simani Gaseitsiwe, Nathan Georgette, et al.
AIDS (London, England)|July 4, 2006
Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in BotswanaRoger L Shapiro, Ibou Thior, Peter B Gilbert, et al.
Plos One|August 9, 2020
Hepatitis B virus prevalence and vaccine antibody titers in children HIV exposed but uninfected in BotswanaKabo Baruti, Kayla Lentz, Motswedi Anderson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 10, 2019
Cytomegalovirus Viremia in HIV-1 Subtype C Positive Women at Delivery in Botswana and Adverse Birth/Infant Health OutcomesNatasha O Moraka, Sikhulile Moyo, Gloria Mayondi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 20, 2005
Serum concentrations of antimycobacterial drugs in patients with pulmonary tuberculosis in BotswanaJordan W Tappero, Williamson Z Bradford, Tracy B Agerton, et al.
AIDS Care|July 13, 2019
Barriers and facilitators to linkage to care and ART initiation in the setting of high ART coverage in BotswanaPoloko Kebaabetswe, Kutlo Manyake, Etienne Kadima, et al.
Medicine|November 26, 2019
Undetectable proviral deoxyribonucleic acid in an adolescent perinatally infected with human immunodeficiency virus-1C and on long-term antiretroviral therapy resulted in viral rebound following antiretroviral therapy termination: A case report with implications for clinical careCatherine Kegakilwe Koofhethile, Sikhulile Moyo, Kenanao Peggy Kotokwe, et al.
Pageof 27

Showing results (141-150 of 268) with videos related to

Sort By:
Pageof 27
The Journal of Infectious Diseases|October 16, 2012
Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in BotswanaJennifer Y Chen, Heather J Ribaudo, Sajini Souda, et al.
The New England Journal of Medicine|July 23, 2019
Neural-Tube Defects and Antiretroviral Treatment Regimens in BotswanaRebecca Zash, Lewis Holmes, Modiegi Diseko, et al.
The Lancet. HIV|July 17, 2019
Long-acting or extended-release antiretroviral products for HIV treatment and prevention in infants, children, adolescents, and pregnant and breastfeeding women: knowledge gaps and research prioritiesSharon Nachman, Claire L Townsend, Elaine J Abrams, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 2, 2013
No clinically significant drug-resistance mutations in HIV-1 subtype C-infected women after discontinuation of NRTI-based or PI-based HAART for PMTCT in BotswanaSajini Souda, Simani Gaseitsiwe, Nathan Georgette, et al.
AIDS (London, England)|July 4, 2006
Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in BotswanaRoger L Shapiro, Ibou Thior, Peter B Gilbert, et al.
Plos One|August 9, 2020
Hepatitis B virus prevalence and vaccine antibody titers in children HIV exposed but uninfected in BotswanaKabo Baruti, Kayla Lentz, Motswedi Anderson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 10, 2019
Cytomegalovirus Viremia in HIV-1 Subtype C Positive Women at Delivery in Botswana and Adverse Birth/Infant Health OutcomesNatasha O Moraka, Sikhulile Moyo, Gloria Mayondi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 20, 2005
Serum concentrations of antimycobacterial drugs in patients with pulmonary tuberculosis in BotswanaJordan W Tappero, Williamson Z Bradford, Tracy B Agerton, et al.
AIDS Care|July 13, 2019
Barriers and facilitators to linkage to care and ART initiation in the setting of high ART coverage in BotswanaPoloko Kebaabetswe, Kutlo Manyake, Etienne Kadima, et al.
Medicine|November 26, 2019
Undetectable proviral deoxyribonucleic acid in an adolescent perinatally infected with human immunodeficiency virus-1C and on long-term antiretroviral therapy resulted in viral rebound following antiretroviral therapy termination: A case report with implications for clinical careCatherine Kegakilwe Koofhethile, Sikhulile Moyo, Kenanao Peggy Kotokwe, et al.
Pageof 27